Your English writing platform
Discover LudwigExact(5)
This approach, by taking disease status into account when imputing, could theoretically lead to more accurate imputation and powerful association test.
None had been taking disease modifying anti-rheumatic drugs.
Patients taking disease modifying anti-rheumatic drugs (DMARDs) were eligible if they were on a stable dose for at least 3 months before screening.
Patients in the disease modifying drug strategy who remaining taking disease modifying drugs (n=58) or switched to tumour necrosis factor inhibitors (n=46) had similar 12 month outcomes in all analyses.
This white matter profile was identified after taking disease severity into account; moreover, a similar emphasis of white matter tract alterations was identified when the bvFTD group was compared with the AD group, suggesting that involvement of these tracts may be a relatively specific index of pathologies in the bvFTD spectrum.
Similar(55)
"We've been taking diseases that aren't even related to each other, but because fatigue is the unifying symptom, we've thrown them in the same bucket and treated them the same," Dimmock says.
In recent studies, quality of life is defined differently taking disease-specific variables into account (health-related quality of life (HRQL)).
Reductions in lymphocyte subset counts were not significantly different in patients who were taking disease-modifying anti-rheumatic drugs (DMARDs, including methotrexate, azathioprine, leflunomide and mycophenolate mofetil) (n = 14), prednisone (n = 18) or tumor necrosis factor alpha (TNF-α) inhibitors (n = 6) (p>0.5, data not shown).
At inclusion, 551 (95.0%) patients were taking disease-modifying drugs.
On entry to the study, 71 patients (81%) were taking disease-modifying antirheumatic drugs.
Furthermore, because they may not require intensive medical oversight associated with taking disease-modifying drugs, older patients may not attend MS clinics as often as those recently diagnosed.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com